Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06725550 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 years 2 months later Apr 2, 2026 → Jun 28, 2030
Enrollment reduced 92% 120 → 10 participants
See other at-risk trials from University of Cincinnati

Record History

  1. Primary completion pushed from Apr 2, 2026 to Jun 28, 2030 Sponsor changed: Indiana University to University of Cincinnati · Enrollment reopened · Enrollment increased: 10 → 120 participants · 5 morev4 Show 8 more changesShow less
    • Sponsor changed: Indiana University to University of Cincinnati
    • Enrollment reopened
    • Enrollment increased: 10 → 120 participants
    • Start date: Aug 25, 2025 to Jul 1, 2026
    • Completion pushed from Apr 2, 2027 to Jun 28, 2031
    • Secondary endpoints: details revised at 2 of 11 entries
    • Study site revised
    • Publications: 4 to 11

    See this version in full on ClinicalTrials.gov ↗

  2. Enrollment reduced: 120 → 10 participants Primary completion moved earlier from Aug 31, 2029 to Apr 2, 2026 · Enrollment closed, study ongoing · Completion moved earlier from Aug 30, 2030 to Apr 2, 2027 · 1 morev3 Show 4 more changesShow less
    • Primary completion moved earlier from Aug 31, 2029 to Apr 2, 2026
    • Enrollment closed, study ongoing
    • Completion moved earlier from Aug 30, 2030 to Apr 2, 2027
    • Site details revised
  3. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Feb 1, 2029 to Aug 31, 2029 · Start date changed from estimate of Jan 6, 2025 to Aug 25, 2025 · Completion date: Feb 1, 2030 to Aug 30, 2030 · 2 morev2 Show 5 more changesShow less
    • Primary completion date: Feb 1, 2029 to Aug 31, 2029
    • Start date changed from estimate of Jan 6, 2025 to Aug 25, 2025
    • Completion date: Feb 1, 2030 to Aug 30, 2030
    • Site details revised
    • Study title expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupuncture analgesia in patients with sickle cell disease.
Trial Details
NCT Number NCT06725550
Lead Sponsor University of Cincinnati
Conditions Sickle Cell Disease, Pain, Acupuncture, Quantitative Sensory Testing, Magnetic Resonance Imaging, Circulating Biomarkers, Electroencephalography, Functional Near-infrared Spectroscopy
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov